Sunshine Biopharma Inc. (SBFM)
↓ Download CSV- Sector Manufacturing
- Incorporated CO
- Fiscal year ends Dec 31
In fiscal 2025, Sunshine Biopharma Inc. reported revenue of $36.31M, up 4.1% from the prior year. The company ran a net loss, with a net margin of -16.5% and a gross margin of 33.8%. It held $30.08M in total assets against $7.04M in total liabilities.
Key ratios (FY2025)
33.8%
Gross margin
-17.2%
Operating margin
-16.5%
Net margin
-25.9%
Return on equity
+4.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.31M | $34.87M | $24.09M | $4.35M | $228.4K | $71.4K | $21.1K | $0 | $0 | — |
| Cost of Revenue | $24.05M | $24.20M | $15.75M | $2.65M | $117.8K | $25.8K | $11.1K | $0 | $0 | — |
| Gross Profit | $12.26M | $10.67M | $8.34M | $1.70M | $110.6K | $45.6K | $10.1K | $0 | $0 | — |
| Operating Income | -$6.23M | -$5.81M | -$4.79M | -$27.00M | -$2.44M | -$576.9K | -$641.6K | -$1.16M | -$857.2K | -$993.1K |
| Net Income | -$5.98M | -$5.13M | -$4.51M | -$26.74M | -$12.44M | -$2.78M | -$1.66M | -$2.16M | -$1.04M | -$3.50M |
| EPS (Diluted) | $-1.44 | $-7.32 | $-351.36 | $-1.76 | $-4.76 | $-2.73 | $-0.15 | $-0.71 | $-0.02 | $-0.01 |
| Total Assets | $30.08M | $30.56M | $27.35M | $29.24M | $2.20M | $1.05M | $98.1K | $1.15M | $257.5K | $64.4K |
| Total Liabilities | $7.04M | $7.06M | $6.14M | $7.62M | $1.99M | $2.00M | $833.5K | $1.20M | $830.8K | $274.1K |
| Shareholders' Equity | $23.04M | $23.50M | $21.21M | $21.63M | $211.7K | -$954.8K | -$735.4K | -$55.8K | -$573.4K | -$209.7K |
| Cash & Equivalents | — | — | — | $21.83M | $2.05M | $989.9K | $40.5K | $110.5K | $107.5K | $57.5K |
| Operating Cash Flow | -$5.33M | -$12.52M | -$8.78M | -$5.25M | -$1.83M | -$657.3K | -$495.8K | -$512.8K | -$543.5K | -$314.2K |
| Capital Expenditures | $174.5K | $1.66M | $82.3K | $194.0K | $0 | $1.2K | $860 | $18.9K | $3.7K | $3.4K |
| Shares Outstanding | 4.91M | 2.58M | 14.0K | 22.59M | 2.59M | 1.73M | 35.32M | 4.28M | 45.94M | 769.40M |